Covid-19: Three purchasing behaviour trends at molecular labs (Asia-Pacific)

Wed, 24th Feb 2021

Article tags In-vitro diagnostics Molecular Diagnostics (MDx)Asia IVD Gateway

Covid-19 has not only impacted test volumes but also spurred changes in test practices and purchasing behaviour in Asia-Pacific’s (APAC’s) molecular diagnostics (MDx) labs.

EIU Healthcare surveyed some 300 MDx labs across APAC to understand how they are responding to Covid-19 and identify what they need to manage the demands of Covid-19 testing more successfully.

Download the infographic and find out:

Percentage of labs surveyed that have already expanded their testing capacity through instrument purchases
Percentage of labs surveyed that plan to further expand testing capacity through instrument purchases
What is the demand for respiratory panel testing?
How important is a local/regional supply of IVD tests and instruments for labs?
How IVD companies can support labs in navigating Covid-19 testing demands?

Download infographic

Simply fill in the form below to access the infographic

Sign up for our EIU Healthcare newsletter and never miss an insight from our specialists and analysts.

We will email you when new articles are published on this topic.

Wed, 24th Feb 2021 Article tags In-vitro diagnostics Molecular Diagnostics (MDx)Asia IVD Gateway